Terug
72
88
72
62
Dagbereik
€ 97,45
€ 102,01
52-Weeksbereik
€ 45,88
€ 193,07
Volume
104.886
50D / 200D Gem.
€ 122,92
/
€ 118,80
Vorige Slotkoers
€ 99,49
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 8,4 | 0,2 |
| P/B | 1,8 | 3,0 |
| ROE % | 29,8 | 3,6 |
| Net Margin % | 8,1 | 3,8 |
| Rev Growth 5Y % | 27,5 | 9,7 |
| D/E | 1,1 | 0,2 |
Koersdoel Analisten
Hold
€ 205,00
+104.2%
Forward K/W
6,51
Forward WPA
€ 15,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
910,48M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 17,56
€ 16,79 – € 18,62
|
947,42M | 1 |
| FY2026 |
€ 15,41
€ 14,74 – € 16,35
|
910,48M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | € 5,56 | € 1,61 | -71,0% |
| 2025-11-19 | € 1,81 | € 7,76 | +328,7% |
| 2025-10-08 | -€ 5,43 | -€ 3,02 | +44,3% |
| 2025-05-13 | € 2,29 | € 2,56 | +11,8% |
| 2025-03-31 | -€ 0,12 | € 11,12 | +9366,7% |
| 2024-11-08 | -€ 0,24 | -€ 1,72 | -616,7% |
| 2024-08-08 | -€ 0,29 | -€ 0,07 | +75,9% |
| 2024-05-08 | N/A | -€ 0,10 | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 27,47% annually over 5 years — strong growth
Earnings grew 35,67% over the past year
ROE of 29,76% indicates high profitability
Generating 245,60M in free cash flow
P/E of 8,44 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 54,89%
Groei
Revenue Growth (5Y)
27,47%
Revenue (1Y)82,36%
Earnings (1Y)35,67%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
29,76%
ROIC30,36%
Net Margin8,09%
Op. Margin31,49%
Veiligheid
Debt / Equity
1,07
Current Ratio3,41
Interest Coverage12,40
Waardering
P/E Ratio
8,44
Forward P/E6,51
P/B Ratio1,81
EV/EBITDA2,77
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 82,36% | Revenue Growth (3Y) | 88,00% |
| Earnings Growth (1Y) | 35,67% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 27,47% | Earnings Growth (5Y) | -14,52% |
| Profitability | |||
| Revenue (TTM) | 875,26M | Net Income (TTM) | 70,79M |
| ROE | 29,76% | ROA | 7,71% |
| Gross Margin | 50,76% | Operating Margin | 31,49% |
| Net Margin | 8,09% | Free Cash Flow (TTM) | 245,60M |
| ROIC | 30,36% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,07 | Current Ratio | 3,41 |
| Interest Coverage | 12,40 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 8,44 | Forward P/E | 6,51 |
| P/B Ratio | 1,81 | P/S Ratio | 0,68 |
| PEG Ratio | 1,77 | Forward PEG | N/A |
| EV/EBITDA | 2,77 | Fwd EV/EBITDA | 29,42 |
| Forward P/S | 0,66 | Fwd Earnings Yield | 15,36% |
| FCF Yield | 41,09% | ||
| Market Cap | 597,70M | Enterprise Value | 763,51M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 875,26M | 479,95M | 247,65M | 219,29M | 331,53M |
| Net Income | 70,79M | 52,18M | -45,79M | -424,78M | 132,59M |
| EPS (Diluted) | 10,48 | 9,71 | -10,39 | -100,36 | 33,55 |
| Gross Profit | 444,28M | 196,26M | 34,77M | 15,42M | 179,28M |
| Operating Income | 275,63M | 130,62M | -31,77M | -406,60M | 170,26M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 918,53M | 655,32M | 398,25M | 431,75M | 394,65M |
| Total Liabilities | 495,09M | 453,43M | 319,14M | 311,42M | 203,07M |
| Shareholders' Equity | 329,45M | 146,34M | 61,45M | 95,86M | 114,65M |
| Total Debt | 351,39M | 340,30M | 275,76M | 267,20M | 178,55M |
| Cash & Equivalents | 185,57M | 43,58M | 22,00M | 34,26M | 36,12M |
| Current Assets | 538,81M | 292,48M | 90,85M | 97,97M | 154,02M |
| Current Liabilities | 157,91M | 140,87M | 58,31M | 54,86M | 37,69M |
Strategiescores
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#90 of 1049
#20 of 619
#44 of 158
Custom
Full Throttle
#26 of 148
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026
Ingestapt
Full Throttle
Mar 24, 2026